Portal de investigación
OPICAPONA, TRASTORNOS DE CONTROL DE IMPULSOS (TCI) Y OTROS SÍNTOMAS PSIQUIÁTRICOS EN LA ENFERMEDAD DE PARKINSON.
Datos básicos
- Código:
- IMT-OPI-2018-01
- Protocolo:
- IMT-OPI-2018-01
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- Año de finalización:
- 2021
Objetivos del proyecto
Observaciones: Estado Comité: APROBADO CEIm
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
A 3.9-Mb Deletion on 2p11.2 Comprising the REEP1 Gene Causes Early-Onset Atypical Parkinsonism.
Baviera-Muñoz R; (...); Espinós C
Article. 10.1212/NXG.0000000000000642. 2021
Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study.
Freire-Alvarez, Eric; (...); Escamilla-Sevilla, Francisco
Article. 10.1016/j.compbiomed.2024.109504. 2024
ATP7B AND OTHER GENES RESULTING IN WILSON DISEASE (WD) PHENOTYPE
Sanchez-Monteagudo, A; (...); Berenguer, M
Meeting Abstract. 2019
Clinical and genetic characteristics of 21 Spanish patients with biallelic pathogenic SPG7 mutations.
Baviera-Muñoz R; (...); Espinós C
Article. 10.1016/j.jns.2021.118062. 2021
Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.
Baviera-Munoz, Raquel; (...); Aller, Elena
Article. 10.1212/NXG.0000000000200038. 2022
Efectos adversos y complicaciones de la infusión intestinal continua de levodopa-carbidopa en una cohorte de pacientes con enfermedad de Parkinson de un hospital terciario.
Campins-Romeu, Marina; (...); Martinez-Torres, Irene
Article. 10.33588/rn.7405.2021482. 2022
Effectiveness and safety of levodopa-entacapone-carbidopa infusion in Parkinson disease: A real-world data study.
Santos-García D; (...); Mata M
Article. 10.1111/ene.16535. 2024
Erenumab vs galcanezumab in a very difficult-to-treat migraine population. Efficacy and safety
Samuel, DI; (...); Jose, NMM
Meeting Abstract. 2021
Erenumab vs galcanezumab in a very difficult-to-treat migraine population. Efficacy and safety
Samuel, DI; (...); Jose, NMM
Meeting Abstract. 2021
Estimulación cerebral profunda combinada del núcleo subtalámico y el globo pálido interno en la enfermedad de Parkinson.
Campins-Romeu M; (...); Martínez-Torres I
Case Reports. 10.33588/rn.7703.2022250. 2023
Gait Function after High-Intensity Focused Ultrasound Thalamotomy for Essential Tremor: Searching for Technique Optimization.
Sastre-Bataller, Isabel; (...); Martinez-Torres, Irene
Article. 10.1159/000527374. 2023
Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain.
Sánchez-Monteagudo A; (...); Espinós C
Article. 10.1111/cge.13719. 2020
Genomic analysis of coding and regulatory regions using NGS in early-onset parkinsonism: a multicentric study
Osuna-Lopez, M; (...); Hoenicka, J
Meeting Abstract. 2019
Glucocerebrosidase activity and atypical parkinsonism: a multi-centre exploratory study
Velasco, RA; (...); Canovas, AA
Meeting Abstract. 2020
Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.
Marino, Zoe; (...); Anguera, Anna
Article. 10.3390/jcm12144823. 2023
Hereditary Spastic Paraplegia 7 Presenting as Multifocal Dystonia with Prominent Cranio-Cervical Involvement
Campins-Romeu, M; (...); Martinez-Torres, I
Letter. 10.1002/mdc3.13257. 2021
Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1.
García-Ramos R; (...); Martínez Castrillo JC
Article. 10.1016/j.nrl.2020.05.010. 2021
Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2.
García-Ramos R; (...); Mir P
Article. 10.1016/j.nrl.2020.05.012. 2021
MNCD: A New Tool for Classifying Parkinson's Disease in Daily Clinical Practice.
Santos García D; (...); Ignacio, AS
Article. 10.3390/diagnostics12010055. 2021
MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing Lesion Volume
Campins-Romeu, Marina; (...); Martinez-Torres, Irene
Article. 10.1038/s41531-024-00843-7. 2024
MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing Lesion Volume (vol 10, 230, 2024)
Campins-Romeu, Marina; (...); Martinez-Torres, Irene
Correction. 10.1038/s41531-025-00871-x. 2025
Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review.
Gómez-Garre P; (...); Mir P
Review. 10.1111/ene.14638. 2020
Mutations, genes and phenotypes related to movement disorders: a never-ending list
Martinez-Rubio, Dolores; (...); Espinos, Carmen
Meeting Abstract. 2022
Profile of plasma microRNAs as a potential biomarker of Wilson's disease.
Sanchez-Monteagudo, Ana; (...); Espinos, Carmen
Article. 10.1007/s00535-024-02135-6. 2024
Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel
Baviera-Munoz, R.; (...); Martinez-Torres, I.
Letter. 10.1016/j.nrl.2021.10.002. 2022
Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel.
Baviera-Muñoz R; (...); Martinez-Torres I
Article. 10.1016/j.nrleng.2021.10.002. 2022
Smoking is associated with age at disease onset in Parkinson's disease.
Rosas I; (...); Bandrés-Ciga S
Article. 10.1016/j.parkreldis.2022.03.005. 2022
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Martin-Flores, N; (...); Int Parkinson's Dis Genomics Conso
Article. 10.1002/mds.27770. 2019
-
-
-
PlumX Metrics
- Citations
- Citation Indexes: 19
- Policy Citations: 2
- Captures
- Readers: 63
- Mentions
- Blog Mentions: 1
- News Mentions: 6
Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain
Baviera-Munoz, Raquel; (...); Bataller, Luis
Article. 10.1002/mdc3.13740. 2023
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life.
Santos-Garcia, Diego; (...); Mir, Pablo
Article. 10.3233/JPD-225073. 2023
STUB1 Mutations as Possible Genetic Modifiers in Spinocerebellar Ataxia Type 8.
Baviera-Munoz, Raquel; (...); Aller, Elena
Article. 10.1002/mds.29910. 2024
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
Alonso-Canovas A; (...); Walter U
Article. 10.1016/j.parkreldis.2019.09.032. 2019
-
-
PlumX Metrics
- Citations
- Citation Indexes: 18
- Policy Citations: 2
- Captures
- Readers: 28
- Mentions
- News Mentions: 1
Transcranial ultrasound in atypical parkinsonism: how reliable is it in real clinical practice? A multi-centre comprehensive study
Canovas, AA; (...); Walter, U
Meeting Abstract. 2019
Treatment failure with anti-CGRP therapy: should we discontinue the treatment or switch it?
Castellanos, CN; (...); Insa, SD
Meeting Abstract. 2021
Treatment failure with anti-CGRP therapy: should we discontinue the treatment or switch it?
Castellanos, CN; (...); Insa, SD
Meeting Abstract. 2021
Unilateral MRIgFUS thalamotomy: Long-term follow-up in fragile X-associated tremor/ataxia syndrome.
Campins-Romeu M; (...); Sastre-Bataller I
Case Reports. 10.1016/j.nrleng.2024.09.004. 2024
Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease
Santos-Garcia, Diego; (...); Alvarez-Santullano, Marina Mata
Article. 10.3390/brainsci14121244. 2024
Which patient related outcome best reflects the willing of a patient to continue with an anti-CGRP monoclonal preventive treatment? A sub-analysis of a prospective study
Castellanos, CN; (...); Insa, SD
Meeting Abstract. 2021